97 related articles for article (PubMed ID: 15436758)
1. Methylandrostenediol, a non-virilizing steroid hormone with testosterone-like effects.
HOMBURGER F; KASDON SC; FISHMAN WH
J Clin Invest; 1950 Jun; 29(6):823. PubMed ID: 15436758
[No Abstract] [Full Text] [Related]
2. Methylandrostenediol: a non-virilizing derivative of testosterone in metastatic cancer of the breast.
HOMBURGER F; KASDON SC; FISHMAN WH
Proc Soc Exp Biol Med; 1950 May; 74(1):162-4. PubMed ID: 15430420
[No Abstract] [Full Text] [Related]
3. [Influence of the administration of testosterone, methylandrostenediol and 19-nortestosterone on urinary elimination of estrogens and corticoids].
SUARDI L
Minerva Med; 1959 Oct; 50():3407-12. PubMed ID: 13835496
[No Abstract] [Full Text] [Related]
4. Methylandrostenediol; a protein-anabolic steroid with little androgenic activity.
GORDAN GS; EISENBERG E; MOON HD; SAKAMOTO W
J Clin Endocrinol Metab; 1951 Feb; 11(2):209-12. PubMed ID: 14814201
[No Abstract] [Full Text] [Related]
5. [A new synthetic steroid, methylandrostenediol].
LAMARCA V
Prog Med (Napoli); 1953 Feb; 9(3):78-83. PubMed ID: 13056051
[No Abstract] [Full Text] [Related]
6. Complications of testosterone therapy in the female; the use of methylandrostenediol as a substitute.
ROBINSON WW
Q Rev Surg; 1953 Sep; 10(3):163-5. PubMed ID: 13100620
[No Abstract] [Full Text] [Related]
7. INFLUENCE OF ADMINISTRATION OF METHYLANDROSTENEDIOL ON ELECTROPHEROGRAM OF SERUM PROTEINS IN C3HF VIRGIN MICE WITH EXPERIMENTAL MAMMARY CARCINOMA.
STOLK A
Acta Morphol Neerl Scand; 1964; 5():295-301. PubMed ID: 14121943
[No Abstract] [Full Text] [Related]
8. [USE OF THE ANABOLIC HORMONE METHYLANDROSTENEDIOL IN THE COMPLEX TREATMENT OF CHILDREN WITH RHEUMATISM].
BEREZHKOV LF; ABDULLAEV AR
Pediatriia; 1963 Apr; 42():34-8. PubMed ID: 14063532
[No Abstract] [Full Text] [Related]
9. Complications of testosterone therapy in the female; the use of methylandrostenediol as a substitute.
ROBINSON WW
West J Surg Obstet Gynecol; 1953 Feb; 61(2):79-82. PubMed ID: 13029453
[No Abstract] [Full Text] [Related]
10. [Comparative study of local changes in connective tissue induced by testosterone propionate, dehydroepiandrosterone, methylandrostenediol and cholesterol].
RUBENS-DUVAL A; VILLIAUMEY J
Ann Endocrinol (Paris); 1956 Oct; 17(5):637-41. PubMed ID: 13411661
[No Abstract] [Full Text] [Related]
11. [Changes in the vaginal smear in rats treated with testosterone propionate and methylandrostenediol].
BERLINGIERI D
Arch Ostet Ginecol; 1959; 64():938-55. PubMed ID: 13799559
[No Abstract] [Full Text] [Related]
12. [Effects of a new methylandrostenediol derivative (methylandrostenediol 3-propionate) on protein anabolism].
MASSONS JM
Rev Iber Endocrinol; 1955; 2(10):421-32. PubMed ID: 13290275
[No Abstract] [Full Text] [Related]
13. Effect of prolonged administration of anabolic and androgenic steroids on reproductive function in the mare.
Turner JE; Irvine CH
J Reprod Fertil Suppl; 1982; 32():213-8. PubMed ID: 6762438
[TBL] [Abstract][Full Text] [Related]
14. Hormonal factors in the production of experimental renal and cardiovascular disease; synergism between somatotrophic hormone and methylandrostenediol.
SALGADO E; SELYE H
J Lab Clin Med; 1955 Feb; 45(2):237-46. PubMed ID: 13233650
[No Abstract] [Full Text] [Related]
15. Transport of steroid hormones through the rat blood-brain barrier. Primary role of albumin-bound hormone.
Pardridge WM; Mietus LJ
J Clin Invest; 1979 Jul; 64(1):145-54. PubMed ID: 447850
[TBL] [Abstract][Full Text] [Related]
16. Metabolic and clinical effects of methylandrostenediol in human subjects.
PARTRIDGE JW; BOLING L; DEWIND L; MARGEN S; KINSELL LW
J Clin Endocrinol Metab; 1953 Feb; 13(2):189-202. PubMed ID: 13034903
[No Abstract] [Full Text] [Related]
17. [Methylandrostenediol: physiological effects; preliminary therapeutic results].
NETTER A; CHEVALLIER J; MOLHO S
Bull Mem Soc Med Hop Paris; 1952 Apr 25-May 2; 68(14-15):516-9. PubMed ID: 14954453
[No Abstract] [Full Text] [Related]
18. [On the administration of methylandrostenediol during pregnancy].
VANDEKERCKHOVE D
Ann Endocrinol (Paris); 1954; 15(4):513-6. PubMed ID: 13229004
[No Abstract] [Full Text] [Related]
19. On a singular ovarian change produced by methylandrostenediol (MAD).
SELYE H
J Obstet Gynaecol Br Emp; 1955 Jun; 62(3):364-6. PubMed ID: 14392514
[No Abstract] [Full Text] [Related]
20. Adrenal steroidogenesis in methylandrostenediol-induced hypertension.
McCall AL; Stern J; Dale SL; Melby JC
Endocrinology; 1978 Jul; 103(1):1-5. PubMed ID: 744061
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
